A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
Clinical trial NCT07024602 · RECRUITING
Trial details
- NCT number
- NCT07024602
- Sponsor
- Ascletis Pharma (China) Co., Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-06-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.